Latest Earnings Results: Q2 '26
Estimated EPS
-$0.76
Reported EPS
-$0.77
Surprise
-1.09%
Estimated Rev
$2.59M
Reported Rev
$3.09M
Surprise
+19.44%
• Reported GAAP EPS of -$0.57 up 53.66% YoY • Reported revenue of $3.09M down -45.83% YoY • MediWound reaffirmed its full-year 2026 revenue guidance of $2426 million, which is supported by expected second-half contributions from the Master Services Agreement and other government-funded programs for MediWound.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.71 | -- | -- | N/A |
Q2 '26 | -$0.76 | -$0.77 | -1.09% | MISSED |
Q1 '26 | -$0.65 | -$0.23 | 64.80% | BEAT |
Q4 '25 | -$0.65 | -$0.56 | 13.83% | BEAT |
Q3 '25 | -$0.81 | -$0.24 | 70.43% | BEAT |